J Med Chem 58:73707380 Gotfredsen CF, Molck AM, Thorup I et al (2014) The human GLP-1 analogs liraglutide and semaglutide: absence of histopathological effects on the pancreas in nonhuman primates
Knowing what to expect makes symptoms less alarming and helps people stick with treatment
In Ozempics case, it is being used for weight management instead of diabetes care
At Slinic, your monthly clinical check-in specifically addresses these concerns not just whether the medication is producing weight loss
For chronic weight management, the FDA-approved indications generally include adults with a BMI of 30 or greater, or BMI 27 or greater with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease)
Rosenthal JH, Mauersberger H: Effects on blood pressure of the alpha-glucosidase inhibitor acarbose compared with the insulin enhancer glibenclamide in patients with hypertension and type 2 diabetes mellitus